61 %The pooled seroprotection rate was 61% in people living with HIV.
Gabonfièvre jaunepublished 2024The Lancet. Global healthPubMeddocument of 5 observations
Gold tier: mechanically validated evidence, with its primary source.
5 evidence items · page 1 / 1
61 %The pooled seroprotection rate was 61% in people living with HIV.
Gabonfièvre jaunepublished 2024The Lancet. Global healthPubMeddocument of 5 observations
76 %The pooled seroprotection rate was 76% in an endemic setting.
Gabonfièvre jaunepublished 2024The Lancet. Global healthPubMeddocument of 5 observations
2,895 individualsThe studies comprised 2895 individuals vaccinated 10–60 years ago.
Gabonfièvre jaunepublished 2024The Lancet. Global healthPubMeddocument of 5 observations
47 %The pooled seroprotection rate was 47% in children aged 9–23 months at time of vaccination.
Gabonfièvre jaunepublished 2024The Lancet. Global healthPubMeddocument of 5 observations
94 %The pooled seroprotection rate was 94% among healthy adults in a non-endemic setting.
Gabonfièvre jaunepublished 2024The Lancet. Global healthPubMeddocument of 5 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.